Meat and Milk Withdrawal Times
Relatively few studies have been conducted to determine drug metabolism and excretion in goats. Label information specifically for goats also is rarely available in the United States, because few drugs are approved by the Food and Drug Administration Center for Veterinary Medicine
Table A.1 Drugdosagesusedingoats.
| Drug Acepromazine | Dose 0.2 mg/kg IM | Indication Tetanus | Chapter 5 |
| Acepromazine | 0.05-0.10 mg/kg IV | Preanesthetic sedation | 17 |
| Acepromazine | 0.3 mg/kg IV | Sedation for bronchoalveolar lavage | 9 |
| Acetic acid 5% (vinegar) | 0.5-1 l PO | Urea toxicosis | 19 |
| Activated charcoal | 0.75-2 g/kg PO | Ethylene glycol poisoning | 12 |
| Activated charcoal | 1 g/kg PO | Organophosphate toxicosis, chlorinated hydrocarbon toxicosis | 5 |
| Albendazole | 20 mg/kg PO divided into 2 doses of 10 mg/ kg at 12 h | Gastrointestinal strongyles | 10 |
| Albendazole | 10-15 mg/kg PO | Tapeworms, liver flukes | 10, 11 |
| Alphaxalone | 4.5 mg/kg slowly IV | Short-term anesthesia | 18 |
| Ammonium chloride | 200-300 mg/kg/day | Urinary acidification | 12 |
| Ammonium chloride | 0.5-1% of diet DM | Urolithiasis prevention | 12 |
| Ammonium tetrathiomolybdate | 100 mg PO SID for up to 3 wk in conjunction with 1 g sodium sulfate PO SID | Copper toxicosis | 7 |
| Amoxicillin | One commercial bovine mastitis tube every 12-24 h, two or three treatments | Mastitis | 14 |
| Ampicillin | 5-10 mg/kg IM BID | Bacterial pneumonia | 9 |
| Ampicillin | 15 mg/kg SC TID | Prevention of cystitis post surgically | 12 |
| Ampicillin sodium | 10-50 mg/kg IV or IM QID | Meningo-encephalitis | 5 |
| Amprolium | 25-50 mg/kg PO SID for 5 d | Coccidiosis | 10 |
| Aspirin | 100 mg/kg PO BID in goats with a developed rumen and taper down to lowest dose that maintains comfort | Joint pain (CAE), laminitis, meningitis adjunct | 4, 5 |
| Atipamezole | 0.08-0.1 mg/kg slowly IV | Reversal of medetomidine | 17 |
| Atipamezole | 0.125-0.175 mg/kg, half slowly IV and half IM | Reversal of xylazine | 17 |
| Atropine sulfate | 0.6-1 mg/kg SC or IM, repeat as needed | Organophosphate poisoning | 5 |
| Atropine | 0.08 mg/kg IM | Reduce salivation for devocalization | 9 |
| Buparvaquone | 2.5 mg/kg IM once | Theileriosis | 7 |
| Bupivacaine | Up to 2 mg/kg in local block, with dexmedetomidine | Disbudding | 18 |
| Butorphanol | 0.2 m/kg IM | Postsurgical analgesia | 17 |
| Calcium borogluconate 23% | 50-100 mL SC | bgcolor=white>Oxalate poisoning12 | |
| Calcium chloride | 40 mg/kg in each testis | Chemical castration | 13 |
| Calcium sodium versenate | 110 mg/kg IV divided into two treatments 6 h apart for 3-5 d | Lead poisoning | 5 |
| Ceftiofur | 1.1-2.2 mg/kg/d IM | Bacterial pneumonia | 9 |
| Charcoal, activated | 1 g/kg PO | Chlorinated hydrocarbon toxicosis | 5 |
| Chloramphenicol | Do not use in USA 10 mg/kg IV BID where permitted | Forbidden in USA Salmonellosis | 10 |
| Cloprostenol | 0.125-0.250 mg IM | Luteolysis, correction of hydrometra | 13 |
| Closantel | 10-20 mg/kg PO (risk of blindness with overdose) | Liver flukes | 11 |
| Closantel | 7.5 mg/kg | Haemonchus | 10 |
| Clorsulon | 7 mg/kg PO | Liver flukes | 11 |
| Drug | Dose | Indication | Chapter | |||||
| Clostridium perfringens C and D antitoxin | 5 mL SC | Prophylaxis of enterotoxemia | 10 | |||||
| C. perfringens C and D antitoxin | 15-20 mL IV, repeat every 3-4 h | Treatment of enterotoxemia | 10 | |||||
| Colostrum | 20% of bw PO over first 24 h | Failure of transfer of passive immunity | 19 | |||||
| Danofloxacin | Do not use in USA | Forbidden in USA | ||||||
| Danofloxacin | 6 mg/kg SC, repeated in 48 h | Mycoplasmosis | 4 | |||||
| Decoquinate | 0.5-1 mg/kg/d PO in feed, for at least 28 d | Coccidiosis prevention | 10 | |||||
| Decoquinate | 2.5 mg/kg/d PO | Cryptosporidiosis. This dose forbidden in USA | 10 | |||||
| Decoquinate | 2 mg/kg/d PO | Toxoplasmosis prevention This dose forbidden in USA | 13 | |||||
| Detomidine | 0.01-0.02 mg/kg IM | Moderate sedation | 17 | |||||
| Dexamethasone | 0.1 mg/kg/d IV | Adjunct-listeriosis | 5 | |||||
| Dexamethasone | 1-2 mg/kg IM or IV | Cerebral edema from polio-encephalomalacia | 5 | |||||
| Dexamethasone | 20-25 mg SC or IM | Induction of parturition | 13 | |||||
| Dexamethasone | 0.44 mg/k IM once | Toxic mastitis | 14 | |||||
| Dextrose | See Glucose | |||||||
| Diazepam | 0.5-1.5 mg/kg IV | Convulsions, tetanus | 5 | |||||
| Diazepam | 0.1-0.5 mg/kg IV | Urolithiasis, to relax urethra | 12 | |||||
| Diazepam | 0.5 mg/kg IV | Preanesthetic sedation | 17 | |||||
| Diethylcarbamazine | 40-60 mg/kg/d PO 1-6 d | Setariasis | 5 | |||||
| Diminazene aceturate | 3.5 mg/kg IM once | Trypanosomosis | 7 | |||||
| Diminazene aceturate | 3.0 mg/kg IM SID 1 or 2 d | Babesiosis | 7 | |||||
| Dioctyl sodium sulfosuccinate (DSS) | 15-30 mL PO | Bloat | 10 | |||||
| Doxapram HCl | 1-1.5 mg/kg IV or sublingually | Resuscitation of neonate | 13 | |||||
| Enrofloxacin | Do not use in USA | Forbidden in USA | ||||||
| Epinephrine | 0.02-0.03 mg/kg IV | Anaphylaxis | 9, 10 | |||||
| Epinephrine 1 : 1000 | 1 mL IM | Uterine relaxation for obstetric manipulation | 13 | |||||
| Eprinomectin | 1 mg/kg topical | Gastrointestinal strongyles | 10 | |||||
| Eprinomectin | 0.4 mg/kg PO | Gastrointestinal strongyles | 10 | |||||
| Eprinomectin | 0.5-1.0 mg/kg topical | Muellerius | 9 | |||||
| Equine chorionic gonadotropin (PMSG) | 400-750 IU IM 48 h before progestogen withdrawal | Induction of estrus out of season | 13 | |||||
| Fenbendazole | 10 mg/kg PO | Dictyocaulus, gastrointestinal strongyles | 9, 10 | |||||
| Fenbendazole | 15 mg/kg | Tapeworms | 10 | |||||
| Fenbendazole | 15-30 mg/kg PO | Muellerius | 9 | |||||
| Fenbendazole | 50 mg/kg/d for 5 d PO | Cerebrospinal nematodiasis | 5 | |||||
| Florfenicol | 40 mg/kg SC every 1-2 d | Bacterial pneumonia | 9 | |||||
| Flumethrin | 1 mg/kg topical pour-on | bgcolor=white>Louse control2 | ||||||
| Drug | Dose | Indication | Chapter | |||||
| Flunixin meglumine | 1 mg/kg/d IV, IM, or PO | Laminitis | 4 | |||||
| Flunixin meglumine | 1.1-2.2 mg/kg SID or BID IV or PO | Muscle trauma (predation or post surgically) | 4, 12 | |||||
| Flunixin meglumine | 1.1 mg/kg IV BID | Anti-inflammatory, pain relief | 12, 13, 17 | |||||
| Flunixin meglumine | 2.2 mg/kg IV, IM, or PO | Pain relief with pneumonia | 9 | |||||
| Flunixin meglumine | 1-2 mg/kg IV or IM BID | Meningo-encephalitis | 5 | |||||
| Furosemide | 1 mg/kg IV | Cerebral edema | 5 | |||||
| Furosemide | 5 mg/kg IV | Lung edema from anaphylaxis | 9 | |||||
| Furosemide | 50-100 mg IM or IV | Udder edema | 14 | |||||
| Gentamicin | 3 mg/kg IV or IM TID | Meningo-encephalitis | 5 | |||||
| Gentamicin | 1 mg/kg IM or SC TID | Salmonellosis | 10 | |||||
| Glucose | 25-50 g IV as 5% or 10% solution | Pregnancy toxemia, ketosis | 19 | |||||
| Glucose 20% solution | 25-50 mL IP | Hypoglycemia in neonate | 19 | |||||
| Griseofulvin | 25 mg/kg/d PO for 3 wk | Ringworm, rarely justified | 2 | |||||
| Halofuginone lactate | 0.1 mg/kg PO SID for 7 d Narrow margin of safety | Cryptosporidiosis | 10 | |||||
| Hyoscine plus metoclopramide plus vitamin E/selenium compound | 0.3 mg/kg plus 0.5 mg/kg plus 0.l mg/kg IM once | Abomasal bloat in young kids | 10 | |||||
| Imidocarb dipropionate | 1-2 mg/kg once | Babesiosis | 7 | |||||
| Isometamidium chloride | 0.5-1.0 mg/kg IM | Trypanosomosis prophylaxis | 7 | |||||
| Ivermectin | 0.5-20 mg/100 kg SC | Warbles | 2 | |||||
| Ivermectin | 0.2-0.4 mg/kg SC, repeat in 2 and 4 wk | Sarcoptic mange | 2 | |||||
| Ivermectin | 0.2 mg/kg PO | Nose bots | 9 | |||||
| Ivermectin | 0.4 mg/kg PO | Gastrointestinal strongyles | 10 | |||||
| Ivermectin, adjunct to fenbendazole | 0.2 mg/kg/d SC for 5 d | Cerebrospinal nematodiasis | 5 | |||||
| Kanamycin | 5 mg/kg IM or SC TID | Salmonellosis | 10 | |||||
| Ketamine | 6 mg/kg IV or 11 mg/kg IM | General anesthesia | 17 | |||||
| Ketoprofen | 3 mg/kg IV or IM SID | Postsurgical analgesia | 17 | |||||
| Lasalocid | 20-30 g/ton of feed | Coccidiosis prevention | 10 | |||||
| Levamisole | 12 mg/kg PO | Gastrointestinal strongyles | 10 | |||||
| Levamisole | 7.5 mg/kg PO or SC | Dictyocaulus | 9 | |||||
| Lidocaine | Up to 7 mg/kg IM or SC | Local analgesia | 17, 18 | |||||
| Lidocaine 2% | 2-4 mL | Caudal epidural | 17 | |||||
| Lincomycin/spectinomycin | 5 mg/kg/d lincomycin +10 mg/kg/d spectinomycin IM for 3 d | Mycoplasmosis (contagious agalactia) | 4 | |||||
| Magnesium hydroxide | 50 g PO (adult goat) | Rumen acidosis | 19 | |||||
| Medetomidine | 0.005 mg/kg IV or 0.015 mg/kg IM | Deep sedation | 17 | |||||
| Melengestrol acetate (MGA) | 0.125 mg/head BID PO for 10-14 d, followed by a prostaglandin IM | Estrus synchronization in season (not permitted in USA) | 13 | |||||
| Meloxicam | 1 mg/kg SID PO | Joint pain (CAE), muscle trauma (predation), other pain relief | 4, 9, 13 | |||||
| Drug | Dose | Indication | Chapter | |||||
| Meloxicam | Loading dose of 2 mg/kg; daily dose of 1 mg/kg until pain is controlled; then maintenance dose of 0.5-1 mg/kg every other day | Laminitis | 4 | |||||
| Methocarbamol | 22 mg/kg IV | Muscle relaxant (tetanus) | 5 | |||||
| Methylene blue 1% | 4-15 mg/kg IV | Nitrate poisoning | 9 | |||||
| Midazolam | 0.4 mg/kg IV | Preanesthetic sedation | 17 | |||||
| Monensin | 15-20 g/ton of feed | Coccidiosis prevention | 10 | |||||
| Morantel citrate | 6 mg base/kg PO | Paramphistomes | 10 | |||||
| Morantel tartrate | 10 mg/kg PO | Gastrointestinal strongyles | 10 | |||||
| Morphine | 0.1 mg/kg IV | Epidural block, dehorning analgesia | 17, 18 | |||||
| Moxalactam | 50 mg/kg IV BID-QID | Meningo-encephalitis | 5 | |||||
| Moxidectin | 0.4 mg/kg PO | Gastrointestinal strongyles | 10 | |||||
| Moxidectin | 0.5-1 mg/kg topical, repeat in 2 and 4 wk | Sarcoptic mange | 2 | |||||
| Niacin | 1 g/animal/d IM or PO | Pregnancy toxemia prevention and treatment | 19 | |||||
| Niclosamide | 50 mg/kg PO | Tapeworms | 10 | |||||
| Oxfendazole | 30 mg/kg PO twice a week for 4 wk | Echinococcosis | 9 | |||||
| Oxytetracycline | 10 mg/kg IV BID at least 3 d | Listeriosis | 5 | |||||
| Oxytetracycline | 10 mg/kg IV once | Tick-borne fever | 7 | |||||
| Oxytetracycline | 10 mg/kg IM or SC SID for 1 or 2 d | Anaplasmosis | 7 | |||||
| Oxytetracycline | 15 mg/kg/d SC at least 5 d | Mycoplasmosis | 4 | |||||
| Oxytetracycline | 5 mg/kg/d IV for 5 d (combined with intramammary therapy) | Gangrenous mastitis | 14 | |||||
| Oxytetracycline | 20 mg/kg SC SID | Actinomycosis | 3 | |||||
| Oxytetracycline, long-acting | 20 mg/kg SC or IM once | Dermatophilosis, foot rot or foot scald, infectious keratoconjunctivitis, heartwater | 2, 4, 6, 8 | |||||
| Oxytetracycline, long-acting | 20 mg/kg SC or IM every 3 d | Chlamydiosis, other abortion diseases | 13 | |||||
| Oxytocin | 5 IU IM or SC BID-TID | Retained placenta, milk letdown | 13 | |||||
| Oxytocin | 50 IU IM BID for 4 d | Correction of hydrometra | 13 | |||||
| Paromomycin | 100 mg/kg/d PO | Cryptosporidiosis | 10 | |||||
| Penicillamine | 50 mg/kg/d PO for 7 d | Copper toxicosis | 7 | |||||
| Penicillin G, procaine | 20 000 IU/kg/d IM for 7-14 d | Staphylococcal dermatitis | 2 | |||||
| Penicillin G, procaine | 20 000-40 000 IU/kg/d IM | Bacterial pneumonia | 9 | |||||
| Penicillin G, procaine | 22 000 IU/kg IM BID | Prevention of cystitis post surgically | 10 | |||||
| Penicillin G, procaine | 25 000 IU/kg IM BID | Tetanus | 5 | |||||
| Penicillin G, procaine | 44 000 IU/kg SID for 2 d | Anthrax | 7 | |||||
| Penicillin G, sodium | 40 000 IU/kg IV QID followed by penicillin G procaine 20 000 IU/kg IM BID | Listeriosis | 5 | |||||
| Penicillin G, sodium | 20 000-40 000 IU/kg IV or IM QID | Meningo-encephalitis | 5 | |||||
| Pentobarbital | 30 mg/kg IV | General anesthesia | 17 | |||||
| Phenylbutazone | 10 mg/kg/d PO | Joint pain (CAE), laminitis | 4 | |||||
| Drug | Dose | Indication | Chapter | |||||
| Poloxalene | 100 mg/kg PO | Bloat | 10 | |||||
| Praziquantel | 5-15 mg/kg PO | Tapeworms | 10, 11 | |||||
| Praziquantel | 25-60 mg/kg PO | Schistosomosis | 8 | |||||
| Praziquantel | 20 mg/kg PO SID for 2 d | Eurytrema spp. pancreatic flukes | 11 | |||||
| Prednisone, prednisolone | 1 mg/kg IM BID for 7-10 d then taper | Pemphigus foliaceus | 2 | |||||
| Propofol | 3-6 mg/kg IV slowly | Anesthesia induction | 17, 18 | |||||
| Proprionylpromazine | 1 mg/kg IM | Protrusion of the penis for examination | 12 | |||||
| Propylene glycol | 60 mL PO BID or TID | Pregnancy toxemia, ketosis | 19 | |||||
| Prostaglandin F2 alpha (dinoprost) | 5-10 mg IM | Luteolysis, correction of hydrometra | 13 | |||||
| Pyrantel tartrate | 25 mg/kg PO | Gastrointestinal strongyles | 10 | |||||
| Selenite, sodium | 1 mg/18 kg SC once (follow label for sheep on selenium-vitamin E product) | White muscle disease | 4 | |||||
| Silver nitrate | 5% solution few drops topically SID for 5 d | Severe corneal ulcer | 6 | |||||
| Sodium bicarbonate | 20 g PO (adult goat) | Rumen acidosis | 19 | |||||
| Sodium bicarbonate 1.3% | 125-200 mL IV | Floppy kid disease | 19 | |||||
| Sodium bicarbonate (powder) | 2.5-3.0 g PO (0.5 tsp. mixed with cold water) | Floppy kid disease | 19 | |||||
| Sodium iodide | 20 mg/kg IV or SC, weekly 5-7 wk | Actinobacillosis (not documented in goats) | 2 | |||||
| Sodium iodide | 20 mg/kg IV or SC, weekly 5-7 wk | Actinomycosis | 3 | |||||
| Sodium iothalamate | 2 mL/kg IV up to 28 kg bw. For heavier goats, reduce the total dose to 75% | Radiographic contrast studies of the urinary tract | 12 | |||||
| Sodium nitrite | 22 mg/kg IV | Cyanide poisoning | 9 | |||||
| Sodium thiosulfate | 660 mg/kg IV | Cyanide poisoning | 9 | |||||
| Spiramycin | 50 mg/kg IM then 25 mg/kg/d | Mycoplasmosis | 4 | |||||
| Streptomycin | 20 mg/kg/d 5-7 d | Actinobacillosis (not documented in goats) | 2 | |||||
| Streptomycin | 10 mg/kg BID or TID | Actinomycosis | 3 | |||||
| Streptomycin | 30 mg/kg/d IM at least 5 d | Mycoplasmosis | 4 | |||||
| Streptomycin | 25 mg/kg IM single dose | Leptospirosis | 13 | |||||
| Sulfadimethoxine | 75 mg/kg PO for 5 d | Coccidiosis | 10 | |||||
| Tetanus antitoxin | 10 000-15 000 units IV BID | Tetanus treatment | 5 | |||||
| Tetanus antitoxin | 250-300 IU SC/kid, 500 IU SC/adult | Tetanus prophylaxis | 18 | |||||
| Tetracycline | 5 mg/kg IM or SC SID or BID | Bacterial pneumonia | 9 | |||||
| Tetracycline | 0.5-1 g PO (single dose) | Adjunct-rumen acidosis treatment | 19 | |||||
| Thiamine | 10 mg/kg IV, IM, or SC QID | Polioencephalomalacia | 5 | |||||
| Thiamine | 300-500 mg IM or SC BID | Adjunct-rumen acidosis | 19 | |||||
| Thiamylal sodium | 10 mg/kg IV | Induction of anesthesia | 17 | |||||
| Thiopental sodium | 5-20 mg/kg IV | Induction of anesthesia | 17 | |||||
| Tiamulin | 20 mg/kg/d IM at least 5 d; reported to be severely irritating at injection site; toxic myopathy | Mycoplasmosis (CCPP) | 4, 9 | |||||
| Drug | Dose | Indication | Chapter |
| Tiamulin | 10 mg/kg IM BID | Mycoplasma mastitis | 14 |
| Tiletamine-Zolazepam | 5.5 mg/kg IV | General anesthesia | 17 |
| (Telazol®) | 7.5-10 mg/kg IM | ||
| Tilmicosin | Do not use | May be fatal | |
| Tolazoline | 1.5 mg/kg IV | Xylazine reversal | 17 |
| Triclabendazole | 10 mg/kg PO | Liver flukes | 10 |
| Schistosomosis | 8 | ||
| Trimethoprim-sulfonamide | 16-24 mg/kg IV BID | Meningo-encephalitis | 5 |
| Trimethoprim-sulfonamide | 15 mg/kg IV BID (trimethoprim inactivated in rumen) | Salmonellosis | 10 |
| Trimethoprim with | 20 mg/kg | Tick-borne fever | 7 |
| sulphamethylphenazole and | 50 mg/kg | ||
| sulphadimidine | 50 mg/kg IV once | ||
| Tulathromycin | 2.5 mg/kg SC | Mycoplasma and Mannheimia pneumonia | 9 |
| Tylosin | 10-20 mg/kg IM SID or BID | Bacterial and mycoplasmal pneumonia | 9 |
| Tylosin | 20 mg/kg/d IM at least 5 d | Mycoplasmosis | 4 |
| Vancomycin | Do not use in USA | Forbidden in USA | |
| Vitamin B12 | 0.01-0.3 mg IM weekly | White liver disease | 11 |
| Xylazine | 0.03-0.04 mg/kg IV | Light sedation | 17 |
| Xylazine | 0.05 mg/kg IV or 0.1 mg/kg IM | Heavy sedation; combine with local anesthesia | 17 |
| Xylazine plus ketamine | 0.22 mg/kg IM xylazine followed in 10 min by 11 mg/kg IM ketamine | General anesthesia | 17 |
| Yohimbine | 0.125 mg/kg IV | Xylazine reversal | 17 |
| Zinc sulfate | 1 g/d/adult goat PO or 10 mg/kg PO SID | Zinc deficiency dermatopathy | 2 |
BID, twice a day; bw, bodyweight; CAE, caprine arthritis encephalitis; d, day; DM, dry matter; h, hour; IM, intramuscular; IU, international units; IV, intravenous; IP, intraperitoneal; PO, orally; QID, four times a day; SC, subcutaneous; SID, once a day; TID, three times a day; tsp., teaspoon; wk, week.
for use in goats in the United States (Webb et al.
2004). In the United States, whenever a drug is administered in any way that differs from the label directions (to a different species, at a different dosage, by a different route), its use is said to be extralabel. Only a veterinarian can legally use a drug in an extralabel fashion, and then only in the presence of a carefully defined veterinarian-client/patient relationship (U.S. Department of Health and Human Services 2005). The veterinarian is then responsible for specifying the time periods before meat or milk can be marketed, to ensure that no illegal drug residues occur. Practitioners working with goats are continually forced to extrapolate from other species (Lofstedt 1987; Riviere et al. 1997) or to select drug dosages or withdrawal periods on empirical bases.A WT is the interval after dosing for all tissue concentrations of a drug or its metabolites to decrease to below a specific concentration established as safe for human consumption by the regulatory agency involved (Riviere et al. 1998). For labeled drugs in the United States, the meat WT is the time required for 99% of treated animals to achieve drug concentrations in muscle, liver, and kidney below the established tolerance concentration (Riviere et al. 1998). The labeled WT takes into account slight errors in dosing and individual differences in clearance rates. The WT must be increased if a drug is given at a higher dosage than is on the label or to a severely diseased animal, as WTs are usually calculated in healthy animals. Typically, the WT is approximately 5-10 times the elimination half-life for the drug, and if the dose administered is doubled, the WT needs to be extended by one half-life, or 10-20%. If, on the other hand, the drug is given to an animal that is more severely compromised by its illness than those for which the drug is labeled, the elimination half-life increases and the WT becomes approximately 10 times the new half-life. A conservative approach is to begin the withdrawal period when the animal appears systemically healthy.
When the drug is given to an animal such as a goat, for which it is not labeled, the distribution and elimination parameters of the drug in that species must be taken into consideration when estimating a WT. Frequently, a smaller species (such as a goat) metabolizes and excretes a drug faster than a larger species of similar physiology (such as cattle), so a cattle WT is often adequate for goats if the same dose is administered (Riviere et al. 1997, 1998). Pharmacokinetic data from the world literature for goats and other species have been tabulated and published by the Food Animal Residue Avoidance Databank (FARAD; Craigmill et al. 2006).American veterinarians should consult FARAD (http:// www.farad.org) for estimated meat and milk withdrawal periods for drugs not labeled for goats in the United States. Several helpful guides to withdrawal periods have been published (Baynes et al. 1997, 2000; Craigmill et al. 1997; Damian et al. 1997; Martin-Jimenez et al. 1997; Haskell et al. 2003, 2005; Gehring et al. 2005; Kukanich et al. 2005; Payne et al. 2006). A summary of some of the extralabel withdrawal intervals from these references, specifically for goats, is available at the FARAD website (http://www. farad.org/wdilookup/wdi_goats.html). Some estimated WTs from FARAD for tranquilizers and general anesthetic drugs are provided in Table 17.1.
In the United States, records must be kept for at least two years after extralabel drug use in goats (Anonymous 1998); some states require a longer period for maintaining records.